| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0073 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |